Genomic Vision (@GenomicVision_) header
Genomic Vision (@GenomicVision_) profile picture

Genomic Vision is a French biotech company providing tools and services to visualize and charaterize single DNA molecules.

Bagneux, Île-de-France
Joined April 2015
Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)Photo by Genomic Vision (@GenomicVision_)
Genomic Vision retweeted
Really pleased to have been part of this study by the Bielinsky lab @AKBiela studying the functional consequences of patient associated mutations in MCM10 nature.com/articles/s41467-0…
5
1
36
Genomic Vision retweeted
CENP-A chromatin prevents replication stress at centromeres to avoid structural aneuploidy dlvr.it/RtvS92
2
3
Genomic Vision retweeted
Des chercheurs de l’Institut Curie ont mis en lumière le rôle de la protéine CENP-A dans la réplication de l’ADN centromérique afin d’empêcher l’apparition d’anomalies chromosomiques structurelles. 🧬 curie.fr/actualite/publicati…
1
1
Genomic Vision retweeted
SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors. dlvr.it/Rs4DdG
1
1
SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors. dlvr.it/Rs4HMC
1
1
Genomic Vision retweeted
Thank you to all who participated in the BIO-Europe Spring® Digital ticket giveaway! Congrats to Imen Mestiri from @GenomicVision_ - you are the lucky winner of the free ticket! 🎉 Don't forget to register to the event if you haven't yet 👉🏻loom.ly/Da66_Rc 👈🏻 @EBDgroup
1
1
Genomic Vision retweeted
Clinical and Translational Report in this issue of CellStemCell: MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia cell.com/cell-stem-cell/full…
1
2
8
Neat proteomic analysis + cell expts by @DrAndyBlackford's group showing which Bloom syndrome complex components interact with ssDNA binding protein RPA. RPA-binding promotes recruitment of BLM to ssDNA damage sites e.g., stalled replication forks. nature.com/articles/s41467-0…
1
5
Great work from our own Fiona Simpkins!
In this @NatureComms , @Penn_OCRC team investigates the effect of a new combination of inhibitors in ovarian cancer models. Fork asymmetry has been assessed by #molecularcombing in platinum-resistant cell lines, treated with PARPi, ATRi or a combination. rdcu.be/ccbGg
1
2
7
Ruggiano and @Kramadan2 discuss the roles of DNA-protein crosslink (DPC) proteases, which digest the protein component of crosslinks, in DPC repair and beyond. nature.com/articles/s42003-0…
3
6
I am delighted to be speaking at the PARP & DDR Inhibitors Digital Summit taking place in just 3 weeks, from January 26 – 28. If you would like to hear from me and other expert speakers, you can register your place here: ter.li/midsq2
3
9
Online Now: CARM1 regulates replication fork speed and stress response by stimulating PARP1 dlvr.it/Rq1xbh
1
13
2
76
Genomic Vision retweeted
We are immensely pleased to continue our long-term association with Genomic Vision. We are completely assure of Genomic Vision management's conviction to achieve the set objectives and with Winance financing arrangement in place, and
1
1
1
2
Genomic Vision retweeted
We are very pleased to share our latest published work from the lab. Phenomenal effort by @elaine_sanij and the entire team! nature.com/articles/s41467-0… @PearsonRick @PeterMacRes
2
9
5
48
Very pleased to see this great work by so many wonderful collaborators finally published! #CancerResearch nature.com/articles/s41467-0…
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
2
11
So proud of this work and our team @PearsonLab1 We are excited that this new treatment approach shows promising potential in some ovarian cancers that currently have very limited treatment options @PeterMacRes @WEHI_research @JCSMR @SVIResearch @QIMRBerghofer
An inhibitor of RNA polymerase I overcomes resistance to PARP inhibitors in PDX models of high grade serous ovarian cancer. go.nature.com/36BBP2O #CancerResearch @elaine_sanij @PearsonRick @PeterMacCC @PeterMacRes
4
5
26